• Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

  • Feb 6 2025
  • Length: 33 mins
  • Podcast

Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

Listen for free

View show details

  • Summary

  • Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity.

    https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha

    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
    📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4
    📖Paperback: https://amzn.to/4gAXrz4

    💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%.

    SOCIALS:
    📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
    🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
    👾: https://discord.gg/ZHeUh7WV
    📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
    ❌: https://x.com/manonthepen?s=21
    💻: https://www.onthepen.com
    Show more Show less
Show more Show less

What listeners say about Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available